At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
00013 HUTCHMED
Trading 12-05 15:18:55
22.020
-0.220
-0.99%
High22.300
Low21.800
Vol3.00M
Open22.280
D1 Closing22.240
Amplitude2.25%
Mkt Cap19.20B
Tradable Cap19.20B
Total Shares872.00M
T/O66.01M
T/O Rate0.34%
Tradable Shares872.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BOCOM INTL: China's 1st-8th Batch National Drug Procurement Renewal Rules Likely Moderate, Short-Term Catalysts Ample
HUTCHMED (00013) Completes Patient Enrollment for Global Phase III SAFFRON Study Evaluating ORPATHYS® (Savolitinib) and TAGRISSO® (Osimertinib) Combination Therapy in MET-Overexpressed/Amplified NSCLC Post-TAGRISSO® Progression
HUTCHMED Announces Enrollment Completed of Saffron Global Phase Iii Trial of Orpathys® and Tagrisso® Combination for Certain Lung Cancer Patients With Met Overexpression and/or Amplification After Progression on Tagrisso®
HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.